Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2007-09-28Clinical Trial Update: Gemcitabine/Cisplatin +/-Cetuximab in Patients With Locally Advanced or Metastatic EGFR-Positive Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating gemcitabine and cisplatin with or without cetuximab in EGFR-positive pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2007-06-22Clinical Trial Update: Trial of Pemetrexed for Patients With Pancreatic Cancer Which Cannot be Treated With Surgery or is Metastatic [Phase 2]
This document reports the completion of a Phase 2 clinical trial evaluating pemetrexed for pancreatic cancer that is unresectable or metasta…
-
CLINICAL_TRIALS trial_result · 2007-06-22Clinical Trial Update: Neoadjuvant Chemotherapy for Resectable Cancer of the Pancreatic Head [Phase 2]
A Phase 2 neoadjuvant chemotherapy trial for resectable cancer of the pancreatic head has completed. The update notes the trial status as CO…
-
CLINICAL_TRIALS trial_result · 2007-06-14Clinical Trial Update: Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic Cancer [Phase 3]
ClinicalTrials.gov entry indicates a Phase III trial evaluating gemcitabine, curcumin, and celecoxib (Celebrex) in advanced or inoperable pa…
-
CLINICAL_TRIALS trial_result · 2007-06-08Clinical Trial Update: Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the Pancreas [Phase 2]
Phase 2 trial update of talabostat in combination with gemcitabine for stage IV pancreatic cancer has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2007-05-17Clinical Trial Update: A Phase II Study of Combine Modality Therapy in Locally Advanced Pancreatic Cancer [Phase 2]
This update describes a Phase II study of combination modality therapy for locally advanced pancreatic cancer, sponsored by the National Hea…
-
CLINICAL_TRIALS trial_result · 2007-05-08Clinical Trial Update: Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic Cancer [Phase 2]
This is a Phase 2 clinical trial update on weekly dosing of an integrative chemotherapy combination for advanced pancreatic cancer. The curr…
-
CLINICAL_TRIALS trial_result · 2007-05-04Clinical Trial Update: A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancreatic Cancer [Phase 2]
Pfizer conducted a multicenter Phase 2 trial of CI-1040 in patients with advanced colorectal cancer, breast cancer, non-small cell lung canc…
-
FDA approval · 2007-04-26FDA Approved: FLUOROURACIL — Original Application (Accord Healthcare, Inc.)
FDA approved Accord Healthcare’s original application for Fluorouracil as a generic injectable chemotherapy agent for multiple cancers.
-
CLINICAL_TRIALS trial_result · 2007-04-19Clinical Trial Update: Biliary Tissue Sampling Using a Cytology Brush or the GIUM Catheter [Phase 1]
A Phase 1 clinical trial is evaluating biliary tissue sampling using a cytology brush or the GIUM catheter in patients with pancreatic cance…
-
CLINICAL_TRIALS trial_result · 2007-02-19Clinical Trial Update: Cancer Detection in Pancreatic Cysts
A completed University of Pittsburgh-sponsored trial investigated detecting cancer within pancreatic cysts.
-
CLINICAL_TRIALS trial_result · 2007-01-26Clinical Trial Update: A Study With LY293111, Gemcitabine and Placebo in Patients With Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating LY293111 in combination with gemcitabine versus gemcitabine with placebo for pancreatic cancer has completed.
-
CLINICAL_TRIALS research · 2007-01-08Clinical Trial Update: Proteomic Analysis of HLA Complex in Solid Cancers: Breast, Ovary, Colon, Rectum, Stomach, and Pancreas
This clinical trial update describes a proteomic analysis of the HLA complex across multiple solid cancers, including breast, ovarian, color…
-
CLINICAL_TRIALS trial_result · 2006-09-08Clinical Trial Update: Acupuncture For Pancreatic Cancer Pain [Phase 3]
Phase 3 trial evaluating acupuncture for pancreatic cancer-related pain has completed.
-
CLINICAL_TRIALS trial_result · 2006-07-28Clinical Trial Update: Survivin Peptide Vaccination for Patients With Advanced Melanoma, Pancreatic, Colon and Cervical Cancer [Phase 1, Phase 2]
An early-phase trial investigating a survivin peptide vaccine in patients with advanced melanoma, pancreatic cancer, colon cancer, and cervi…
-
CLINICAL_TRIALS trial_result · 2006-07-19Clinical Trial Update: A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas. [Phase 3]
A Phase 3 trial compared ALIMTA (pemetrexed) plus GEMZAR (gemcitabine) versus GEMZAR alone in unresectable or metastatic pancreatic cancer a…
-
CLINICAL_TRIALS trial_result · 2006-06-29Clinical Trial Update: 32P BioSiliconTM in Addition to Gemcitabine in Pancreatic Cancer [Phase 2]
Clinical trial update on a Phase 2 study evaluating 32P BioSilicon in combination with Gemcitabine for pancreatic cancer.
-
FDA approval ·FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer
FDA approves Rasonque (daraxonrasib), a first-in-class RAS inhibitor, for metastatic pancreatic cancer, marking a novel targeted therapy opt…
-
FDA trial_result ·FDA Permits Expanded Access for Investigational Pancreatic Cancer Drug
FDA issued a safe-to-proceed letter allowing expanded access treatment for an investigational pancreatic cancer drug, daraxonrasib, by Revol…